Hair Relaxer Lawsuit Update, L’Oréal Settles First Trial With 4 Women, 12,743 Federal Cases Still Pending
L’Oréal USA and other hair relaxer makers settled with four women on November 16, 2026, one week into the first trial over claims that chemical hair straighteners cause gynecologic cancer. The amount is confidential, no jury reached a verdict, and the deal covers only those four state-court plaintiffs. It does not create a settlement fund, and it does not resolve the 12,743 hair relaxer cases still pending in federal court in Chicago.
The four women, MaryAnne Lindsey, Surenthia Jenkins, Miranda Lofton and Sandra Simpson, sued in Cook County, Illinois, in 2023 and 2024. Jury selection began November 9. Their attorney, Danielle Ward Mason, said she hoped the settlement would give them a sense of justice. L’Oréal said it remains confident in the safety of its SoftSheen-Carson products and that those products go through rigorous scientific safety evaluation.
If you used chemical relaxers and were later diagnosed with uterine or ovarian cancer, this settlement does not mean you are owed money, and it does not mean you are too late. The sections below explain what was settled, what was not, and what a new claim would require.
Hair Relaxer Lawsuit Settlement: Quick Facts
| Detail | Verified information |
| What happened | Four women settled individual cancer lawsuits against L’Oréal USA and other makers |
| Settlement date | November 16, 2026 |
| Court | Circuit Court of Cook County, Illinois (state court) |
| Trial start | November 9, 2026 (jury selection) |
| Plaintiffs | MaryAnne Lindsey, Surenthia Jenkins, Miranda Lofton, Sandra Simpson |
| Plaintiffs’ attorney | Danielle Ward Mason |
| Settlement amount | Confidential |
| Verdict or liability finding | None |
| Federal litigation | MDL No. 3060, Northern District of Illinois, Judge Mary M. Rowland |
| Pending federal cases | 12,743 as of November 2, 2026 |
| Alleged injuries | Uterine, endometrial and ovarian cancer, plus other reproductive conditions |
| Nationwide settlement or claim form | None |
| First federal bellwether trial | September 7, 2027 (subject to change) |
| State lawsuits against L’Oréal | Arizona (September 2026) and Minnesota (October 2026) |
What Happened in the Cook County Hair Relaxer Trial Against L’Oréal?
The four plaintiffs said long-term use of chemical hair straighteners caused their gynecologic cancers and that the makers failed to warn them. They were the first women in the country to get their hair relaxer cases to a jury.
The case settled during trial. Per Reuters, the plaintiffs’ lawyers described the sum as confidential, and no per-plaintiff figures, diagnoses, release terms or payment timing were made public.
Did L’Oréal admit its hair relaxers cause cancer?
No. No admission of liability was reported, and L’Oréal continues to deny that its products caused any plaintiff’s illness. A confidential settlement ends the dispute between the parties. It is not a finding of fault, and it cannot be used to say what any other plaintiff’s case is worth.
How Much Is the L’Oréal Hair Relaxer Settlement Worth?
Nobody outside the parties knows. Any website that quotes a figure for these four women, or an “average payout” for hair relaxer cases, is guessing.
| Question | Current answer |
| How much did the four women receive? | Not disclosed |
| Did a jury award damages? | No |
| Is there a nationwide L’Oréal hair relaxer settlement fund? | No |
| Is there a public claim form or settlement administrator? | No |
| Can every Dark & Lovely or Optimum user claim money? | No |
| Are the federal lawsuits still active? | Yes |
| Are future settlements guaranteed? | No |
In a personal injury case, the damages a plaintiff can seek generally include medical bills, lost income, pain and suffering, and in some states punitive damages. Families can bring wrongful-death claims. What any individual case is worth turns on the cancer type and stage, treatment (hysterectomy, chemotherapy, radiation), age, fertility loss, and how well the exposure and causation can be proved.

Why Are 12,743 Hair Relaxer Lawsuits Still Pending in Federal Court?
Most federal cases are centralized in In re: Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation, MDL No. 3060, before Judge Mary M. Rowland in the Northern District of Illinois. The Judicial Panel on Multidistrict Litigation created it on February 6, 2023, and its November 2, 2026 report lists 12,743 pending actions. Cases are also pending in state courts, including Cook County.
Is the hair relaxer MDL a class action?
No. Under 28 U.S.C. § 1407, federal cases with common questions of fact are coordinated before one judge for pretrial work such as shared discovery and expert rulings. Each plaintiff keeps an individual lawsuit with their own evidence on exposure, diagnosis and damages. That is why a deal in four Cook County cases does not settle anyone in the MDL, and why there is no single check to claim.
For how a different mass-tort resolution is structured, see J&J’s $5.8 Billion Talc Settlement, Who Is Covered as Another Trial Opens in Massachusetts? and How To Check Your Claim. That litigation is unrelated to hair relaxers.
Which Hair Relaxer Brands and Manufacturers Are Named in the Lawsuits?
| Company | Brands named in the litigation |
| L’Oréal USA / SoftSheen-Carson | Dark & Lovely, Optimum, Mizani |
| Strength of Nature | Just for Me, Motions, African Pride, Soft & Beautiful |
| Namaste Laboratories (Dabur) | ORS Olive Oil |
| Revlon | Crème of Nature and other lines |
| Others | House of Cheatham, Godrej-related entities and additional makers |
The list is not exhaustive, and defendants differ from case to case. Appearing in a lawsuit does not mean every product under a brand name is defective or causes cancer. Formulations and manufacturing periods change, so the exact product, its maker and the years of use matter to any claim.
Which Cancers Are Alleged in the Hair Relaxer Lawsuits?
The core allegations involve hormone-sensitive reproductive cancers. Plaintiffs argue that repeated scalp application of chemical relaxers exposes users to endocrine-disrupting chemicals that can interfere with estrogen.
- Uterine and endometrial cancer: the main injury driving the litigation.
- Ovarian cancer: also central, supported by separate epidemiological research.
- Breast cancer and other conditions: studied, but findings vary and the evidence is less settled.
- Uterine fibroids and endometriosis: not cancers. Some complaints include them, but a fibroid diagnosis does not automatically support the same claim as a cancer diagnosis.
What Did the NIH Sister Study Find About Hair Straighteners and Uterine Cancer?
The litigation began after the National Institutes of Health published its Sister Study findings on October 17, 2022. The analysis followed 33,497 women ages 35 to 74 for nearly 11 years and identified 378 uterine cancer diagnoses. Women who reported using chemical straighteners more than four times in the previous year were more than twice as likely to develop uterine cancer as women who reported no use.
| Group | Estimated uterine cancer risk by age 70 |
| Never used chemical straighteners | 1.64% |
| Frequent users | 4.05% |
The relative risk more than doubled, but the absolute risk stayed low. The study does not mean half of frequent users get cancer.
Does the NIH study prove a specific hair relaxer caused someone’s cancer?
No. The study was observational. It found an association between reported use and later diagnosis, did not collect brand and ingredient detail for every product, and could not prove cause in any individual woman. A separate 2021 NIH-linked study reported an association between hair straightener use and ovarian cancer. Proving legal causation takes more than either study, which is why expert testimony became the key fight in the federal case.
What Did Judge Rowland Rule About Hair Relaxer Cancer Experts in October and November 2026?
In October 2026, Judge Rowland ruled on challenges to plaintiffs’ general-causation experts under Federal Rule of Evidence 702 and Daubert v. Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993). Reporting indicates she allowed key plaintiffs’ expert testimony on whether chemical relaxers can cause uterine and ovarian cancer, and a further ruling on additional experts followed on November 12, with some experts allowed and others excluded in part or whole.
An admissibility ruling is not a finding of liability. It means the testimony met the court’s reliability standard. L’Oréal and the other defendants can still challenge it at trial and argue the science does not show their products caused any plaintiff’s cancer.
Plaintiffs generally have to prove two things: general causation (the product can cause the disease) and specific causation (it did cause this plaintiff’s disease).
When Is the First Federal Hair Relaxer Bellwether Trial?
The first bellwether trial in MDL No. 3060 is scheduled for September 7, 2027. A bellwether is a test case meant to show how juries react to the evidence. A verdict does not decide every other case. The November 16 settlement happened in state court and does not change the federal schedule.
| Date | Development |
| October 17, 2022 | NIH Sister Study published |
| February 6, 2023 | MDL No. 3060 created |
| September 11, 2026 | Arizona sues L’Oréal |
| October 23, 2026 | Minnesota sues L’Oréal |
| November 2, 2026 | JPML reports 12,743 pending federal cases |
| November 9, 2026 | Cook County trial begins with jury selection |
| November 12, 2026 | Further federal expert ruling |
| November 16, 2026 | Four Cook County cases settle |
| December 2026 | Federal case management and case-specific expert discovery dates |
| September 7, 2027 | First federal bellwether trial |
Court dates change often. Check the MDL docket for the current schedule.
Why Did Arizona and Minnesota Sue L’Oréal Over Hair Relaxers?
Arizona Attorney General Kris Mayes sued L’Oréal on September 11, 2026, the first state to sue over alleged cancer risks linked to hair relaxers. Arizona alleges the company hid evidence of cancer risk and seeks penalties and damages, plus an order barring sales unless the products carry a cancer warning.
Minnesota Attorney General Keith Ellison filed a consumer protection suit on October 23, 2026, alleging L’Oréal marketed relaxers as safe to Black women and girls while withholding health information.
These are government allegations, not findings. Neither suit automatically entitles individual buyers to money, and L’Oréal disputes the claims.
What Is L’Oréal Saying About the Hair Relaxer Cancer Claims?
L’Oréal says its products are subject to rigorous scientific safety evaluation, that it follows the regulations of every market where it operates, and that existing studies do not establish a causal link between its products and any plaintiff’s condition. Its 2026 half-year financial report states that, as of June 30, 2026, its U.S. companies were defendants in 11,554 federal MDL proceedings and 1,082 state-court actions. Those are the company’s June figures. The November federal count is newer.
Can You Still File a Hair Relaxer Cancer Lawsuit in 2026?
Potentially, yes. The Cook County settlement did not close the MDL or set a deadline for new claims. But not everyone who used a relaxer has a viable case. A lawyer will generally look at:
- A documented diagnosis, such as uterine, endometrial or ovarian cancer.
- Which products and manufacturers were involved.
- How often and for how many years the products were used, at home or in a salon.
- Medical and scientific evidence tying the exposure to the diagnosis.
- Whether your state’s filing deadline has passed.
The NIH study’s “more than four times a year” figure is a research benchmark, not a legal eligibility rule. No court has set a minimum number of uses or years. Salon professionals who applied relaxers regularly may also have claims.
Do you have to live in Illinois to file?
No. Plaintiffs across the country have cases in the Chicago MDL. Which court is proper and which state’s law applies depend on where you live, where you used the product and where you were diagnosed.
What is the deadline to file a hair relaxer lawsuit?
There is no single national deadline. Each state sets its own statute of limitations for personal injury and wrongful death, commonly somewhere between one and six years. Some states start the clock at diagnosis, others when you knew or should have known of a link to the product, and a few apply statutes of repose. Because the clock may already be running, speak with an attorney licensed in your state soon rather than waiting for a settlement announcement.
How Do Hair Relaxer Lawyers Get Paid, and Is a Settlement Taxable?
Fees. Product liability firms typically take cases on contingency, meaning no upfront fee, and are paid a percentage of any recovery, plus case costs. Percentages vary by firm and state, and are often in the range of one-third to 40 percent. Get the fee agreement in writing and ask how costs are handled. In federal MDLs, courts can also order a separate assessment on recoveries to pay lawyers who did shared work. Ask any firm whether one applies to your case.
Taxes. Under Internal Revenue Code § 104(a)(2), damages received on account of personal physical injury or physical sickness are generally excluded from federal gross income. Punitive damages and interest are generally taxable, and prior medical deductions can affect the treatment. State rules differ, so confirm with a tax professional.
How to Start a Hair Relaxer Cancer Claim
There is no public settlement portal. If you have a possible claim:
- Gather medical records: diagnosis date, pathology reports and treatment history.
- List the products: brand names, years of use and where you bought them.
- Keep evidence: packaging, photos, receipts, salon records or old product photos.
- Write a usage timeline: how often you applied them, who applied them, and any scalp burns or reactions.
- Talk to a product liability attorney about defendants, deadlines, fees and risks.
Do not pay a website to “register” for an L’Oréal settlement. No public claims process exists, and lead-generation sites and scammers often use settlement headlines to collect personal and medical information.
Are Chemical Hair Relaxers Banned or Recalled?
No. The settlement is not a recall or a ban. The FDA regulates cosmetics under the Federal Food, Drug, and Cosmetic Act. Cosmetics do not need FDA premarket approval, but makers are responsible for safety and labeling. The FDA has separately warned that some heat-activated smoothing treatments can release formaldehyde gas. Those products are not necessarily the same as the lye and no-lye relaxers at issue in the lawsuits.
For a different hair-product dispute involving scalp irritation and hair loss rather than cancer, see TRESemmé Lawsuit 2026, Hair Loss Claims, New Cases, Court Rulings and Recall Status.
For the full background on eligibility and the federal docket, see Hair Relaxer Cancer Lawsuit, Where Does MDL No. 3060 Stand in June 2026 and Are You Still Eligible to Join?
L’Oréal Hair Relaxer Lawsuit FAQs
Did L’Oréal settle the hair relaxer cancer lawsuit?
L’Oréal USA and other makers settled with four women in Cook County on November 16, 2026. The broader litigation continues.
How much did the four women get from L’Oréal?
The amount is confidential and has not been made public.
Who are the four women in the L’Oréal settlement?
MaryAnne Lindsey, Surenthia Jenkins, Miranda Lofton and Sandra Simpson.
How many hair relaxer lawsuits are still pending?
The JPML reported 12,743 federal actions as of November 2, 2026. More cases are pending in state courts.
Is there a hair relaxer settlement claim form?
No. There is no nationwide fund, administrator or claim form.
Can Dark & Lovely or Optimum users file a lawsuit?
Possibly, depending on diagnosis, product and usage evidence, and state deadlines. Using a brand does not by itself qualify you.
Do hair relaxers cause uterine or ovarian cancer?
Research links frequent chemical straightener use to higher rates of some cancers. That is an association. It does not prove any single product caused any single person’s cancer, and the defendants dispute causation.
When is the next hair relaxer trial?
The first federal bellwether trial is set for September 7, 2027. Other state-court trials may proceed on their own schedules.
Update Log
- November 17, 2026: Article published after the November 16 Cook County settlement. Federal case count updated to the JPML’s November 2, 2026 report.
What Comes Next
The settlement shows that at least some defendants chose not to take these cases to a verdict. It does not show what any other case is worth. The next signals to watch are further state-court trial dates, any disclosure of settlement terms, new federal expert and summary judgment rulings, and the September 2027 bellwether trial.
Primary sources
- Reuters, “L’Oreal US settles hair relaxer cancer cases during first trial,” November 16, 2026.
- U.S. Judicial Panel on Multidistrict Litigation, Pending MDL Dockets report, November 2, 2026.
- U.S. District Court, Northern District of Illinois, MDL No. 3060, expert evidence orders (October 22 and November 12, 2026).
- National Institutes of Health, “Hair straightening chemicals associated with higher uterine cancer risk,” October 17, 2022.
- National Library of Medicine, hair product use and ovarian cancer risk study (2021), PubMed 34173819.
- Reuters, “Arizona accuses L’Oreal of concealing cancer risks linked to hair relaxers,” September 11, 2026.
- Minnesota Attorney General’s Office, press release, October 23, 2026.
- L’Oréal, 2026 Half-Year Financial Report.
- U.S. FDA, “Hair Dye and Hair Relaxers.”
- 28 U.S.C. § 1407; Fed. R. Evid. 702; 26 U.S.C. § 104(a)(2).
Settlement terms are confidential and were reported through counsel’s statements to Reuters. The private agreements were not independently reviewed.
Researched and written by Israr Ahmad, legal content researcher and founder of AllAboutLawyer.com. All facts verified against Reuters reporting, the Judicial Panel on Multidistrict Litigation, the NIH, the Arizona and Minnesota attorneys general, L’Oréal’s 2026 half-year report and FDA guidance, as of November 17, 2026. Last Updated: November 17, 2026.
This article is for informational purposes only and does not constitute legal or medical advice. Laws vary by state and individual circumstances differ. For advice about your specific situation, consult a qualified attorney or healthcare provider.
About the Author
Israr Ahmad is a legal content researcher with 4+ years of experience covering class action settlements and consumer rights cases. He has researched and published coverage of 2,500+ settlements using verified court records, settlement administrator filings, and government sources. Learn more about Israr.
